Baird Starts Medpace (MEDP) at Neutral
- Wall Street flat as countdown to Trump's swearing-in begins
- Netflix, Inc. (NFLX) Tops Q4 EPS by 1c; Subs Beat Views
- Apple (AAPL) PT Raised to $140 at BofA/Merrill Lynch; iPhone 8 Will be 'Super-Long' Cycle
- Morgan Stanley Upgrades Tesla Motors (TSLA) to Overweight
- CP's (CP) Outgoing CEO Hunter Harrison, Activist Paul Hilal Said Set to Target CSX Corp. (CSX)
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Baird initiated coverage on Medpace (NASDAQ: MEDP) with a Neutral rating and a price target of $35.00.
Shares of Medpace closed at $30.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: SunTrust Robinson Humphrey Starts TransDigm (TDG) at Buy
- UPDATE: SunTrust Robinson Humphrey Starts Spirit AeroSystems (SPR) at Hold
- UPDATE: SunTrust Starts Triumph Group (TGI) at Hold
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesRobert W Baird
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!